Brought to you by 
LabCorp in discussions to acquire CRO PPD for over $8bn; terminated
01 May 2020
Executive Summary
According to industry sources Laboratory Corp. of America Holdings (LabCorp) is in discussions to acquire contract research firm Pharmaceutical Product Development Inc. (PPD) for over $8bn including debt. (LabCorp is one of the parties bidding in an auction for PE-owned PPD.)
Deal Industry
- Biotechnology
- Contract Research, Toxicology Testing-CRO
- Pharmaceuticals
- Services
Deal Status
- Withdrawn
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
LabCorp in discussions to acquire CRO PPD for over $8bn; terminated
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice